ABL Bio Inc. (KOSDAQ:298380)
182,100
-8,300 (-4.36%)
At close: Dec 17, 2025
525.77% (1Y)
| Market Cap | 10.04T |
| Revenue (ttm) | 88.44B |
| Net Income (ttm) | -28.65B |
| Shares Out | 55.13M |
| EPS (ttm) | -575.68 |
| PE Ratio | n/a |
| Forward PE | 907.07 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 760,655 |
| Average Volume | 1,173,242 |
| Open | 190,500 |
| Previous Close | 190,400 |
| Day's Range | 182,100 - 190,600 |
| 52-Week Range | 26,400 - 220,000 |
| Beta | 0.53 |
| RSI | 54.90 |
| Earnings Date | Feb 6, 2026 |